References
- Attia MA. Prevalence of hepatitis B and C in Egypt and Africa. AntivirTher. 1998; 3(Suppl3): 1-9. PubMed | Google Scholar
- Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46(3): 922-938. PubMed | Google Scholar
- Merli MG, Nicolini S, Angeloni S, Rinaldi V, De Santis A, Merkel C et al. "Incidence and natural history of small esophageal varices in cirrhotic patients." Journal of Hepatology. 2003; 38(3): 266-272. PubMed | Google Scholar
- Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND,
Burroughs AK, Planas R et al. Betablockers to prevent gastroesophageal
varices in patients with cirrhosis. N Engl J Med. 2005; 353(21): 2254-2261. PubMed
- Groszmann RJ, Bosch J, Grace ND, Conn HO, Gracia-Tsao G, Navasa M, Alberts J. Hemodynamic events in a prospective randomized trial of Propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990; 99(5): 1401-1407. PubMed | Google Scholar
- The North Italian Endoscopic for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med. 1988; 319(15): 983-9. PubMed | Google Scholar
- Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history and influence on survival. Gastroenterology. 1989; 96(6): 1552-9. PubMed | Google Scholar
- D'Amico G, De Franchis R, a cooperative study group. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology. 2003; 38(3): 599-612. PubMed | Google Scholar
- Villanueva C, Piqueras M, Aracil C, Gomez C, Lopez-Balaguer JM, Gonzalez B et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006; 45(4): 5607-7. PubMed | Google Scholar
- Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008; 47(5): 1604-14. PubMed | Google Scholar
- Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982; 82(5): 968-73. PubMed | Google Scholar
- Fugger R, Herbst F, Mirza D. Combined sclerotherapy and operation for the treatment of bleeding oesophageal varices. Eur J Surg. 1992; 158(9): 485-9. PubMed | Google Scholar
- GraVeo M, BuVoli F, Lanzani G, Donato F, Cesari P, Benedini D et al. Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics. Am J Gastroenterol. 1994; 89(10): 1815-1822. PubMed | Google Scholar
- Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981; 80(4): 800-9. PubMed | Google Scholar
- Farooqi JI, Ahmed H, Ikramullah Q, Ahmed F, Masood-ur R. Predictors of esophageal varices in patients of liver cirrhosis. JPMI. 2007; 21(1): 60-64. Google Scholar
- D'Amico G, PagliaroL, Boch J, Patch D. Pharmacological treatment of portal hypertension: an evidence-based approach. Seminars in Liver Disease. 1999; 19(4): 475-505. PubMed | Google Scholar
- Archampong TNA, Tachi K, Agyei AA, Nkrumah KN. The Significance of variceal haemorrhage in Ghana: a retrospective review. Ghana Med J. 2015; 49(4): 142-146. PubMed | Google Scholar
- Mahassadi AK, Bathaix FY, Assi C, Bangoura AD, Allah-Kouadio EE, Kissi HY et al. Usefulness of noninvasive predictors of oesophageal varices in black African cirrhotic patients in Cote d'Ivoire (West Africa). Gastroenterology Res Pract. 2012; 2012: 216390. PubMed | Google Scholar
- Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, William R. Transection of the oesophagus for the bleeding of the oesophageal varices. Br J Surg. 1973; 60(8): 646-9. PubMed | Google Scholar
- Cales P, Zaboto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H et al. Gastro-esophageal endoscopic features in cirrhosis: observer variability, inter-associations and relationship to hepatic dysfunction. Gastroenterology. 1990; 98(1): 156-162. PubMed | Google Scholar
- Blankson A, Wiredu EK, Gyasi RK, Adjei A, Tettey Y. Sero -prevalence of hepatitis B and C viruses in cirrhosis of the liver in Accra, Ghana. Ghana Med J. 2005; 39(4): 132-137. Google Scholar
- Friedman SL. Hepatic fibrosis. In: Schiff ER, Sorrell MF and Maddrey WC eds. Schiff's Diseases of the Liver. 8th ed. Philadelphia, Pa: Lippincott-Raven. 1999; 371-385.
- Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C et al. Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validati on study based on follow-up. Dig Liver Dis. 2005; 37(10): 779-85. PubMed | Google Scholar
- Mattos AZ, Mattos AA, Vianna FF, Musskopf MI, Pereira-Lima JC, Maciel AC. Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices. Arq Gastroenterol. 2010; 47(3): 275-278. PubMed | Google Scholar
- Ofori-Asenso R, Agyeman AA. Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015). BMC Infect Dis. 2016; 16: 130. PubMed | Google Scholar
- Agyeman AA, Ofori-Asenso R, Mprah A, Ashiagbor G. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis. BMC Infect Dis. 2016; 16: 391. PubMed | Google Scholar
- Iloh GU, Ikwudinma AO. Sero-epidemiology of Hepatitis B surface antigenaemia among adult Nigerians with clinical features of liver diseases attending a primary-care clinic in a resource-constrained setting of eastern Nigeria. North Am J Med Sci. 2013; 5(4): 293-300. PubMed | Google Scholar
- Ayele AG, Solomon GS. Prevalence and risk factors of Hepatitis B and Hepatitis C Virus Infections among Patients with Chronic Liver Diseases in Public Hospitals in Addis Ababa, Ethiopia. ISRN Tropical Med. 2013; 2013: 563821. Google Scholar
- Handady SO, Ahmed MA, Fadl AA, Alawad AAM. Precipitating factors of hepatic encephalopathy among Sudanese patients with Liver Cirrhosis. Medicine Journal. 2015; 2(4): 63-67. Google Scholar
- Patricia LG, Maria da PZG, Carla CM, Ana TM, Carlos SG, Fausto ELP. Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espfrito Santo. Clinics. 2013; 68(3): 291-295. PubMed | Google Scholar
- Wolf DC; cirrhosis, Medscape, August 5th, 2013.
- NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19•2 million participants. The Lancet. 2016; 387(10026): 1377-1396. PubMed | Google Scholar
- Lay CS, Tsai YT, Teg C, Shyu WS, Guo WS, Wu KL et al. Endoscopic vanceal prophylaxis of first variceal bleeding in cirrhotic patients (with high-risk esophageal varices. Hepatology. 1997; 25(6): 1346-1350. PubMed | Google Scholar
- Achinge I G, Malu AO, Okeke EN, Agaba EI, Misauno MA. Prevalence of oesophageal varices in newly diagnosed chronic liver disease patients at The Jos University Teaching Hospital, Jos. Nig Med J. 2011; 52(2): 128-132. Google Scholar
- Chalasani N, Imperiale TF, Ismail A, Sood G, Garey M, Wilcox CM et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999; 94(11): 3285-91. PubMed | Google Scholar